From: Advanced health biotechnologies in Thailand: redefining policy directions
Level 1 Well-established safety and effectiveness | Level 2 Established safety and efficacy, promising effectiveness | Level 3 Clear evidence on harm or disutility | |
---|---|---|---|
Regulators/payers | ✓ | ✓ | |
Health professionals | ✓ | ✓ | ✓ |
Research funders/ researchers | ✓ | ||
Media | ✓ | ||
Public | ✓ | ✓ |